Future Outlook And Stock Price Performance For Microbot Medical Inc (NASDAQ: MBOT)

NOVA

In today’s recent session, 3.76 million shares of the Microbot Medical Inc (NASDAQ:MBOT) have been traded, and its beta is 1.17. Most recently the company’s share price was $2.94, and it changed around $0.24 or 8.89% from the last close, which brings the market valuation of the company to $106.95M. MBOT at last check was trading at a discount to its 52-week high of $3.38, offering almost -14.97% off that amount. The share price’s 52-week low was $0.82, which indicates that the recent value has risen by an impressive 72.11% since then. We note from Microbot Medical Inc’s average daily trading volume that its 10-day average is 1.58 million shares, with the 3-month average coming to 2.38 million.

Microbot Medical Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended MBOT as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Microbot Medical Inc is expected to report earnings per share of -0.12 for the current quarter.

Microbot Medical Inc (NASDAQ:MBOT) trade information

Instantly MBOT has been showing a green trend so far today with a performance of 8.89% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.05 on recent trading dayincreased the stock’s daily price by 3.61%. The company’s shares are currently up 162.50% year-to-date, but still up 12.21% over the last five days. On the other hand, Microbot Medical Inc (NASDAQ:MBOT) is 9.29% up in the 30-day period. We can see from the shorts that 6.41 million shares have been sold at a short interest cover period of 1.42 day(s).

1 analysts expect Microbot Medical Inc to make 2M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 0.00%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 15.51%.

MBOT Dividends

Microbot Medical Inc’s next quarterly earnings report is expected to be released on 2025-May-13.

Microbot Medical Inc (NASDAQ:MBOT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 0.67% of Microbot Medical Inc shares, and 6.52% of them are in the hands of institutional investors. The stock currently has a share float of 6.57%. Microbot Medical Inc stock is held by 51.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.0953% of the shares, which is about 0.46 million shares worth $0.47 million.

BLACKROCK INC., with 0.9253% or 0.14 million shares worth $0.14 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 348.55 shares worth $1.05 million, making up 0.96% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 180.3 shares worth around $0.54 million, which represents about 0.50% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.